You are here: Industry Insights > Generic

News List

Glenmark forays into branded dermatology segment in US expressbpd
December 20, 2018
The branded portfolio for the US market will be developed and commercialised by Glenmark Therapeutics USA
Lupin receives US FDA approval for Clobazam tabs expressbpd
December 18, 2018
The drug is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years of age or older
Glenmark receives ANDA approval for Hydrocortisone Valerate Ointment expressbpd
December 17, 2018
The company is eligible for 180 days of CGT exclusivity upon commercialisation
Celgene Licenses Two Dragonfly Immunotherapy Candidates contractpharma
December 17, 2018
Dragonfly Therapeutics, Inc. has licensed two TriNKET immunotherapy drug candidates to Celgene Corp. and its affiliates for $12 million each plus milestones and royalties.
Mylan says Sanofi loses Lantus insulin patent claims expressbpd
December 14, 2018
Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and paediatric patients with type 1 diabetes to control high blood sugar
Strides Vivimed JV receives approval for Albendazole tabs expressbpd
December 13, 2018
The product, used to treat certain infections caused by tapeworm, will be launched immediately
Lupin launches generic Silodosin Capsules 4mg and 8mg expressbpd
December 05, 2018
An alpha-1 adrenergic receptor antagonist, it is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)
DRL launches Chlorthalidone Tablets, USP in the US market expressbpd
November 29, 2018
The tablets are available in 25 mg tablets in the bottle-count sizes of 100 and 1000, and 50 mg tablets
Glenmark gets US FDA nod for generic acne treatment gel expressbpd
November 21, 2018
The approval granted is for Azelaic Acid Gel, 15 per cent, which is a generic version of Finacea Gel (15 per cent) of Leo Pharma
Glenmark gets US FDA nod for generic acne treatment gel expressbpd
November 20, 2018
Citing market data, the company said for the 12-month period ended September 2018, Finacea Gel (15 per cent ) achieved annual sales of approximately $ 64.1 million.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page